Sickle cell disease is caused by a nnutant form of hemoglobin that polymerizes when exposed to low oxygen tension. Polymerization makes the red blood cells rigid so that they cannot traverse some blood vessels leading to blockage of these vessels which then leads to significant morbidity and mortality. Although polymerization can be thought of as the primary cause of the disease, clinical presentation includes symptoms that result from a host of pathological states including acute and chronic inflammation, stasis, reperfusion injury, endothelial activation and dysfunction, coagulation activation, and excess oxidant stress. The link between polymerization and these pathologies is not clear. However, part ofthe link may be tied to the function of Nitric Oxide (NO), an important signaling molecule. NO is synthesized in endothelial cells of blood vessels and diffuses to neighboring smooth muscle cells where it acts as a signaling molecule, causing muscle relaxation and vasodilation. It also decreases endothelial and platelet activation, acts as an anti-oxidant, and is anti-inflammatory. Sickle red blood cells are fragile, rupturing during transit in the circulation (hemolysis). Several groups have hypothesized that cell-free hemoglobin that is released upon hemolysis efficiently scavenges NO, leading to an NO-related deficiency associated with sickle cell disease. The roles of hemolysis and NO in sickle cell disease remain controversial. This project aims to explore those roles while examining the links between polymerization, hemolysis, and other pathological consequences in sickle cell disease. This project will also examine aspects of therapeutic interventions that involve increasing nitric oxide bioavailability via nitrite therapy. The laboratories participating in this project have recently shown that, contrary to the existing paradigm, nitrite acts as a vasodilator in human circulation that is preferentially released under low oxygen conditions. Results from this project will elucidate mechanistic pathways in the pathology of sickle cell disease and nitric oxide biology and extend these insights to translational studies. As NO is important in many diseases, information gained herein will have wide application.
This proposal aims to further explore the pathology of sickle cell disease by examining the link between the primary cause ofthe disease and clinical outcomes, largely through interactions with the important signaling molecule Nitric Oxide. The work also explores basic mechanisms that will help guide translation to therapeutic strategies aimed at restoring Nitric Oxide bioavailability in sickle cell and other diseases.
|Kim, Jin-Kwang; Moore, David J; Maurer, David G et al. (2015) Acute dietary nitrate supplementation does not augment submaximal forearm exercise hyperemia in healthy young men. Appl Physiol Nutr Metab 40:122-8|
|Liu, Chen; Wajih, Nadeem; Liu, Xiaohua et al. (2015) Mechanisms of human erythrocytic bioactivation of nitrite. J Biol Chem 290:1281-94|
|Kim-Shapiro, Daniel B; Gladwin, Mark T (2015) Pitfalls in measuring NO bioavailability using NOx. Nitric Oxide 44:2-Jan|
|Wang, Dong; Cortés-Puch, Irene; Sun, Junfeng et al. (2014) Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia. Transfusion 54:1712-24|
|Kim-Shapiro, Daniel B; Gladwin, Mark T (2014) Mechanisms of nitrite bioactivation. Nitric Oxide 38:58-68|
|Cortés-Puch, Irene; Wang, Dong; Sun, Junfeng et al. (2014) Washing older blood units before transfusion reduces plasma iron and improves outcomes in experimental canine pneumonia. Blood 123:1403-11|
|Helms, Christine; Kim-Shapiro, Daniel B (2013) Hemoglobin-mediated nitric oxide signaling. Free Radic Biol Med 61:464-72|
|Helms, C C; Marvel, M; Zhao, W et al. (2013) Mechanisms of hemolysis-associated platelet activation. J Thromb Haemost 11:2148-54|
|Bellavia, Landon; DuMond, Jenna F; Perlegas, Andreas et al. (2013) Nitroxyl accelerates the oxidation of oxyhemoglobin by nitrite. Nitric Oxide 31:38-47|
|Solomon, Steven B; Wang, Dong; Sun, Junfeng et al. (2013) Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood 121:1663-72|
Showing the most recent 10 out of 17 publications